AWH News and Press, Aspira Women's Health Inc. From 05/11/23

2023-05-11 16:46:13 ET Aspira Women’s Health press release ( NASDAQ: AWH ): Q1 GAAP EPS of -$0.73. Revenue of $2.3M (+27.8% Y/Y). For further details see: Aspira Women’s Health reports Q1 results

First Quarter total product revenue of $2.3 million, an increase of 26% year-over-year First Quarter OvaSuite volume of 6,259 units, an increase of 29% year-over-year First Quarter cash used in operations of $5.7 million, a decrease of 44% year-over-year Conference Call ...

2023-05-11 15:54:44 ET Aspira Women’s Health ( NASDAQ: AWH ) on Thursday said its board approved a 1-for-15 reverse stock split of its outstanding common stock. Beginning May 12, the company’s common stock will trade on a split-adjusted basis on the Nasdaq....

AUSTIN, Texas, May 11, 2023 (GLOBE NEWSWIRE) -- Aspira Women’s Health Inc. (“Aspira”) (Nasdaq: AWH), a bio-analytical based women’s health company focused on the development of gynecologic disease diagnostic, tools, today announced a 1-for-15 reverse stock split of its...

NEW YORK, May 11, 2023 (GLOBE NEWSWIRE) -- FMW Media's New to The Street, a premier business television show, announces their featured corporate guests' lineups on shows 466, 467, and 468. Each show is to air across New to The Street's syndicated televised platforms on Newsmax and the ...

AUSTIN, Texas, May 11, 2023 (GLOBE NEWSWIRE) -- Aspira Women’s Health Inc. (Nasdaq: AWH), a bio-analytical based women’s health company focused on gynecologic disease, today announced it has signed an exclusive licensing agreement with the Dana-Farber Cancer Institute (“DFCI&...

AUSTIN, Texas, May 09, 2023 (GLOBE NEWSWIRE) -- Aspira Women’s Health Inc. (“Aspira”) (Nasdaq: AWH), a bio-analytical based women’s health company focused on the development of gynecologic disease diagnostic tools, today announced it the appointment of three new indepe...

2023-04-27 17:18:34 ET Aspira Women’s Health ( NASDAQ: AWH ) said Thursday preliminary OvaSuite volume rose 29% to 6,259 tests performed during the first quarter of 2023, compared to 4,846 tests for the same period last year. The company continues to expect full-year 20...

Preliminary first quarter 2023 volume was 6,259 tests, an increase of 29% compared to last year, the highest volume quarter in the company’s history Management to host its first quarter earnings conference call on Thursday, May 11 at 4:30 pm AUSTIN, Texas, April 27, 2023 (G...

2023-03-22 22:49:01 ET Aspira Women's Health Inc. (AWH) Q4 2022 Earnings Conference Call March 22, 2023 16:30 ET Company Participants Nicole Sandford - President & Chief Executive Officer Ryan Phan - Chief Scientific Officer & Chief Operating Officer Marl...